Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
Counsel
P
P
Department of Diagnostic and Interventional Radiology, Royal Perth Hospital, Perth, Western Australia. pcouncel@wadoctor.com.au
Khangure
M
M
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000473:pathology; D013116:Spinal Cord / Q000473:pathology; D013118:Spinal Cord Diseases / Q000139:chemically induced* / Q000473:pathology
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D008727:Methotrexate